Literature DB >> 18234297

Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.

Scott D Richard1, Thomas C Krivak, Anthony Castleberry, Sushil Beriwal, Joseph L Kelley, Robert P Edwards, Paniti Sukumvanich.   

Abstract

PURPOSE: Management for stage IB cervical cancer with intraoperative positive pelvic lymph nodes (LNs) is controversial. We compare 5-year survival rates for women with completed vs. abandoned radical hysterectomy (RH) who were treated with postoperative radiation therapy (RT). PATIENTS AND METHODS: We identified all women diagnosed with stage IB cervical carcinoma from the Surveillance, Epidemiology, and End Results database from 1988-1998. Women with positive LN involvement who had undergone a complete pelvic and para-aortic lymphadenectomy were compared for 5-year survival based on whether a RH was completed or abandoned at the time of surgery. All women then received postoperative RT. Survival rates were calculated using the Kaplan-Meier method, and the Chi square test was used for all univariate analysis.
RESULTS: From a cohort of 3116 women diagnosed with stage IB cervical cancer, 265 (8.7%) had positive pelvic LNs and a complete pelvic and para-aortic lymphadenectomy. Of these women, 163 had completion of their RH while RH was abandoned in 55. Positive pelvic LNs averaged 2.58+/-2.37 in the completed RH group and 2.42+/-1.63 in the abandoned RH group. Median follow-up was 6.42 years in the completed RH group and 5.75 years in the abandoned RH group. Five-year survival for the completed RH group was 69% compared with 71% in patients with abandoned RH (p=0.46).
CONCLUSIONS: Treatment for patients with positive pelvic LNs at the time of RH should be determined by overall morbidity of therapy since equivalent 5-year survival was found between the completed and abandoned RH groups.

Entities:  

Mesh:

Year:  2008        PMID: 18234297     DOI: 10.1016/j.ygyno.2007.12.002

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer.

Authors:  Shaleen K Botting; Hala Fouad; Kyler Elwell; Bill A Rampy; Salama A Salama; Daniel H Freeman; Concepcion R Diaz-Arrastia
Journal:  Transl Oncol       Date:  2010-06-01       Impact factor: 4.243

Review 2.  New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer.

Authors:  Diego Rossetti; Salvatore Giovanni Vitale; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-05-02

3.  Debulking metastatic pelvic nodes before radiotherapy in cervical cancer patients: a long-term follow-up result.

Authors:  Tak-Hong Cheung; Keith Wing-Kit Lo; So-Fan Yim; Sau-Han Yau; May Mei-Yung Yu; Wing-Kay Yeung
Journal:  Int J Clin Oncol       Date:  2011-03-25       Impact factor: 3.402

4.  The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.

Authors:  Heidi J Gray; Erin Seifert; Victor G Sal Y Rosas; Katrina F Nicandri; Wui-Jin Koh; Barbara A Goff
Journal:  Obstet Gynecol Int       Date:  2010-04-28

5.  From open radical hysterectomy to robot-assisted laparoscopic radical hysterectomy for early stage cervical cancer: aspects of a single institution learning curve.

Authors:  H W R Schreuder; R P Zweemer; W M van Baal; J van de Lande; J C Dijkstra; R H M Verheijen
Journal:  Gynecol Surg       Date:  2010-04-13

6.  Clinical observation of laparoscopic radical hysterectomy for cervical cancer.

Authors:  Xiang-Hua Yin; Zhong-Qin Wang; Shi-Zhang Yang; Hong-Yan Jia; Min Shi
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 7.  IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers.

Authors:  Nadeem R Abu-Rustum; Roberto Angioli; Arthur E Bailey; Vance Broach; Alessandro Buda; Michelle R Coriddi; Joseph H Dayan; Michael Frumovitz; Yong Man Kim; Rainer Kimmig; Mario M Leitao; Mustafa Zelal Muallem; Matt McKittrick; Babak Mehrara; Roberto Montera; Lea A Moukarzel; Raj Naik; Silvana Pedra Nobre; Marie Plante; Francesco Plotti; Oliver Zivanovic
Journal:  Int J Gynecol Cancer       Date:  2020-03-30       Impact factor: 3.437

8.  Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer.

Authors:  Salim Abraham Barquet-Muñoz; Gabriel Jaime Rendón-Pereira; Denise Acuña-González; Monica Vanessa Heymann Peñate; Luis Alonso Herrera-Montalvo; Lenny Nadia Gallardo-Alvarado; David Francisco Cantú-de León; René Pareja
Journal:  World J Surg Oncol       Date:  2017-01-14       Impact factor: 2.754

9.  Results from Survey to Assess Current Trends in Surgical Practice in the Management of Women with Early Stage Cervical Cancer within the BGCS Community with an Emphasis on Routine Frozen Section Examination.

Authors:  Kumar Gubbala; Alexandros Laios; Thulumuru Kavitha Madhuri; Pubudu Pathiraja; Krishnayan Haldar; Sean Kehoe
Journal:  Int J Surg Oncol       Date:  2017-07-17

10.  Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma.

Authors:  Yi-Fang Dai; Mu Xu; Li-Ying Zhong; Xiao-Yan Xie; Zhao-Dong Liu; Ming-Xing Yan; Huan Yi; Dan-Mei Lin
Journal:  J Int Med Res       Date:  2018-07-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.